Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19

Summary

The purpose of this research is to see if Intravenous Immunoglobulin (IVIG) can help reduce respiratory complications (respiratory failure and need for a ventilator) caused by coronavirus disease 2019 (COVID-19). The principal investigator has successfully utilized IVIG for patients infected with the influenza virus. The investigator wants to find out if IVIG is equally effective in COVID-19 infection patients, and if IVIG will give the immune system some help to clear the infection naturally.

Timeline

Start

2020-04-28

Primary completion

2020-06-23

Completion

2020-06-23

Drugs

Indications